FC
KYNB

FORA Capital’s Kyntra Bio KYNB Stock Holding History

FORA Capital’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-413
Closed -$193K – 445
2023
Q1 		$193K Buy
+413
New +$219K 0.02% 490
2021
Q2 		– Sell
-96
Closed -$84K – 964
2021
Q1 		$84K Buy
+96
New +$102K 0.03% 444
2020
Q3 		– Sell
-267
Closed -$270K – 754
2020
Q2 		$270K Buy
+267
New +$248K 0.09% 284
2020
Q1 		– Sell
-355
Closed -$381K – 1126
2019
Q4 		$381K Buy
+355
New +$362K 0.04% 463

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FORA Capital's KYNB Position: Q2 2023 in Review

FORA Capital sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 413 shares — an estimated $193K sold.

FORA Capital first reported a position in KYNB in Q4 2019 and held it in 4 quarters. The position peaked at $381K in Q4 2019. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

  • FORA Capital reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
  • FORA Capital sold 413 Kyntra Bio shares in Q2 2023, an estimated $193K.
  • FORA Capital first reported a position in Kyntra Bio in Q4 2019 and held it in 4 quarters.
  • FORA Capital's Kyntra Bio position peaked at $381K in Q4 2019.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on FORA Capital's 13F filing for Q2 2023, filed 11 Aug 2023.